Literature DB >> 22159621

[Impact of the myoma arterial embolization by uterine volume, diameter myoma greater and in the ovarian function].

André Bernardo1, Mariano Tamura Vieira Gomes, Rodrigo Aquino Castro, Manoel João Batista Castello Girão, Claudio Emilio Bonduki, Claudio Atsushi Yokoyama.   

Abstract

PURPOSE: To evaluate the impact of uterine artery embolization (UAE) on uterine volume (UV), greater myoma diameter (GMD) and ovarian function three months after the procedure, by transvaginal pelvic ultrasonography (TVPUS) and by the determination of follicle-stimulating hormone (FSH).
METHODS: Thirty patients with leiomyomas were submitted to UAE. TVPUS and FSH determination were performed before and three months after UAE. UV was determined in cm³, GMD in cm and FSH in IU/mL. Data are reported as as mean standard deviation (SD) and were analyzed statistically by the nonparametric Mann-Whitney test.
RESULTS: Twenty-nine patients were analyzed. Before UAE, mean UV was 402.4 165.9 cm³ and GMD was 5.9 2.1 cm. After UAE, mean UV was 258.9 118.6 cm³ and GMD was 4.6 1.8 cm. Mean FSH concentration was 4.9 3.5 IU/mL before UAE and 5.5 4.7 IU/mL after UAE, with p=0.5. There was a 35% reduction of UV and a 22% reduction of GMD, with no changes in FSH values after three months.
CONCLUSION: The procedure significantly reduced UV and GMD but did not cause a significant increase in FSH levels, thus causing no changes in ovarian function.

Entities:  

Mesh:

Year:  2011        PMID: 22159621     DOI: 10.1590/s0100-72032011000800006

Source DB:  PubMed          Journal:  Rev Bras Ginecol Obstet        ISSN: 0100-7203


  2 in total

1.  Myoma Expulsion after Uterine Artery Embolization.

Authors:  Vivian Fernanda do Amaral; Fernanda Yumi Yochiy; Mário Luiz Furlanetto; Spencer Luiz Marques Payão
Journal:  Case Rep Surg       Date:  2021-09-08

2.  Comparing the Use of Uterine Artery Embolization to Gonadotropin-Releasing Hormone Agonists in Shrinking Fibroid Size: A Pilot Study in Kazakhstan.

Authors:  Balkenzhe Imankulova; Alibek Mereke; Nazira Kamzaeva; Talshyn Ukybassova
Journal:  Cent Asian J Glob Health       Date:  2015-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.